APA (7th ed.) Citation

MP, D. C., G, D. S., F, D., C, M., M, R., E, A., . . . BM, C. (2009). Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder. Clinical Therapeutics, 31(12), 2851. https://doi.org/10.1016/j.clinthera.2009.12.010

Chicago Style (17th ed.) Citation

MP, De Candia, et al. "Effects of Treatment with Etizolam 0.5 Mg BID on Cognitive Performance: A 3-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Two-treatment, Three-period, Noninferiority Crossover Study in Patients with Anxiety Disorder." Clinical Therapeutics 31, no. 12 (2009): 2851. https://doi.org/10.1016/j.clinthera.2009.12.010.

MLA (9th ed.) Citation

MP, De Candia, et al. "Effects of Treatment with Etizolam 0.5 Mg BID on Cognitive Performance: A 3-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Two-treatment, Three-period, Noninferiority Crossover Study in Patients with Anxiety Disorder." Clinical Therapeutics, vol. 31, no. 12, 2009, p. 2851, https://doi.org/10.1016/j.clinthera.2009.12.010.